Corton Capital Inc. Gh Research PLC Transaction History
Corton Capital Inc.
- $168 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding GHRS
# of Institutions
34Shares Held
28.3MCall Options Held
10.3KPut Options Held
3.7K-
Bvf Inc San Francisco, CA10.4MShares$130 Million2.72% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.69MShares$83.7 Million0.76% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.86MShares$60.8 Million13.21% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$41.6 Million0.38% of portfolio
-
Verition Fund Management LLC Greenwich, CT918KShares$11.5 Million0.03% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $651M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...